| 111470-1 | Urate (Urine) | LABORDERS.ONTOLOGY |
| 111471-9 | Cortisol Free (Urine) | LABORDERS.ONTOLOGY |
| 111472-7 | Romanesco broccoli IgG Ab (immunoassay) | ALLERGY |
| 111474-3 | Associated risk factor Newborn | NEONAT |
| 111475-0 | XR Ankle - right Lateral and Mortise and Broden W manual stress | RAD |
| 111476-8 | XR Ankle - left Views and Mortise | RAD |
| 111477-6 | XR Ankle - left Views + view W manual stress | RAD |
| 111478-4 | Influenza virus A whole genome segment sequence in Specimen (sequencing) | MICRO |
| 111479-2 | Advanced Explanation of Benefits | DOC.ONTOLOGY |
| 11148-4 | Potassium/Creatinine (Urine) | CHEM |
| 111480-0 | Good Faith Estimate | DOC.ONTOLOGY |
| 111481-8 | Pregnancy risk status | CLIN.RISK |
| 111482-6 | Child Health Surveillance | DOC.ONTOLOGY |
| 111483-4 | Total score Reported.SARC-F | CLIN |
| 111484-2 | How many times have you fallen in the past year (qualitative) | CLIN |
| 111485-9 | How much difficulty do you have climbing a flight of 10 stairs (qualitative) | CLIN |
| 111486-7 | How much difficulty do you have transferring from a chair or bed (qualitative) | CLIN |
| 111487-5 | How much difficulty do you have walking across a room (qualitative) | CLIN |
| 111488-3 | How much difficulty do you have in lifting and carrying 10 pounds (qualitative) | CLIN |
| 111489-1 | Sacropenia screening Reported.SARC-F | PANEL.CLIN |
| 11149-2 | Sodium/Creatinine (Urine) | CHEM |
| 111490-9 | Immunization Invitation Letter | DOC.ONTOLOGY |
| 111491-7 | Preventive Care Invitation Letter | DOC.ONTOLOGY |
| 111492-5 | Gamma globulin in 24 hour Urine (electrophoresis) | CHEM |
| 111493-3 | MDMB-BUTINACA/Creatinine (Urine, confirmatory method) | DRUG/TOX |
| 111494-1 | MDMB-BUTINACA (Urine, qualitative, confirmatory method) | DRUG/TOX |
| 111495-8 | MDMB-BUTINACA (Urine, confirmatory method) | DRUG/TOX |
| 111496-6 | MDMB-4en-PINACA-BA/Creatinine (Urine, confirmatory method) | DRUG/TOX |
| 111497-4 | MDMB-4en-PINACA-BA (Urine, qualitative, confirmatory method) | DRUG/TOX |
| 111498-2 | MDMB-4en-PINACA-BA (Urine, confirmatory method) | DRUG/TOX |
| 111499-0 | ADB-4en-PINACA/Creatinine (Urine, confirmatory method) | DRUG/TOX |
| 1115-5 | Le sup(a) Ag on Red Blood Cells (qualitative) | BLDBK |
| 11150-0 | Blasts/cells (Bone Marrow) | HEM/BC |
| 111500-5 | ADB-4en-PINACA (Urine, qualitative, confirmatory method) | DRUG/TOX |
| 111501-3 | ADB-4en-PINACA (Urine, confirmatory method) | DRUG/TOX |
| 111502-1 | AB-FUBINACA-M3/Creatinine (Urine, confirmatory method) | DRUG/TOX |
| 111503-9 | AB-FUBINACA-M3 (Urine, qualitative, confirmatory method) | DRUG/TOX |
| 111504-7 | 5F-ADB-M7 (synthetic cannabinoid metabolite)/Creatinine (Urine, confirmatory method) | DRUG/TOX |
| 111505-4 | 5F-ADB-M7 (synthetic cannabinoid metabolite) (Urine, qualitative, confirmatory method) | DRUG/TOX |
| 111506-2 | Hepatitis B virus basal core promoter mutation (qualitative, sequencing) | MICRO |
| 111507-0 | Hepatitis B virus precore mutation (qualitative, sequencing) | MICRO |
| 111509-6 | Borrelia sp DNA in Specimen (qualitative, naa with probe detection) | MICRO |
| 11151-8 | Hematocrit of Cord blood (calculation) | HEM/BC |
| 111510-4 | Acinetobacter calcoaceticus-baumannii complex DNA in Lower respiratory specimen (qualitative, naa with non-probe detection) | MICRO |
| 111511-2 | Hepatitis B virus reverse transcriptase gene mutations (qualitative, sequencing) | MICRO |
| 111512-0 | Hepatitis B virus surface Ag DNA mutations (qualitative, sequencing) | MICRO |
| 111516-1 | Ciclopirox in Isolate (minimum inhibitory concentration (mic)) | DRUG/TOX |
| 111517-9 | Tau protein.phosphorylated 217/Amyloid beta 42 peptide | CHEM |
| 111518-7 | Pimozide (Urine, qualitative) | DRUG/TOX |
| 111519-5 | LDL.oxidized | CHEM |